142 related articles for article (PubMed ID: 7029031)
1. Central and peripheral effects of dopamine on the renin-angiotensin-aldosterone system in conscious rats.
Kondo K; Suzuki H; Handa M; Nagahama S; Yasui T; Fujimaki M; Ogihara T; Saruta T
Jpn Circ J; 1981 Sep; 45(9):1121-5. PubMed ID: 7029031
[TBL] [Abstract][Full Text] [Related]
2. Role of dopamine in the regulation of blood pressure and the renin--angiotensin--aldosterone system in conscious rats.
Kondo K; Ebihara A; Suzuki H; Saruta T
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():235s-237s. PubMed ID: 7032812
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the central effects of dopamine and metoclopramide on aldosterone regulation in the rat.
Kawabe H; Kondo K; Hayashi M; Fujimaki M; Nagahama S; Saruta T
Endocrinol Jpn; 1983 Aug; 30(4):543-9. PubMed ID: 6323152
[TBL] [Abstract][Full Text] [Related]
4. Central dopaminergic regulation of aldosterone secretion in sheep.
Huang BS; Malvin RL; Lee J; Grekin RJ
Hypertension; 1987 Aug; 10(2):157-63. PubMed ID: 3301664
[TBL] [Abstract][Full Text] [Related]
5. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
Carey RM; Thorner MO; Ortt EM
J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic blockade of the renin-angiotensin-aldosterone system: effect of high and low sodium intakes.
Gordon MB; Moore TJ; Dluhy RG; Williams GH
Clin Endocrinol (Oxf); 1983 Oct; 19(4):415-25. PubMed ID: 6354522
[TBL] [Abstract][Full Text] [Related]
7. Pressor and hormonal responses to intravenous injection of metoclopramide in normotensive and hypertensive patients.
Kawabe H; Suzuki H; Itaya Y; Saruta T
Jpn J Med; 1990; 29(2):174-9. PubMed ID: 2232366
[TBL] [Abstract][Full Text] [Related]
8. Central effects of angiotensin II and dopamine in sodium-depleted sheep.
Huang BS; Malvin RL; Grekin RJ
Am J Physiol; 1985 May; 248(5 Pt 2):R541-8. PubMed ID: 3887949
[TBL] [Abstract][Full Text] [Related]
9. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
10. Serotoninergic stimulation of aldosterone secretion in the rat in vivo: role of the renin-angiotensin system.
Davies E; Rossiter S; Edwards CR; Williams BC
J Endocrinol; 1991 Sep; 130(3):347-55. PubMed ID: 1719114
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
Sowers JR; Beck FW
Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic control of aldosterone secretion is independent of the renin-angiotensin system in rats.
Sowers JR; Tuck ML; Barrett J; Sambhi MP; Golub MS
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():101s-103s. PubMed ID: 7004716
[TBL] [Abstract][Full Text] [Related]
13. The effect of metoclopramide administration on electrolyte status and activity of renin-angiotensin-aldosterone system in premature infants.
Sulyok E; Ertl T; Varga L; Bódis J; Csaba IF
Pediatr Res; 1985 Sep; 19(9):912-5. PubMed ID: 3900902
[TBL] [Abstract][Full Text] [Related]
14. Effects of intracerebroventricular administration of dopamine and metoclopramide on blood pressure in rats.
Kondo K; Suzuki H; Handa M; Nagahama S; Saruta T
Arch Int Pharmacodyn Ther; 1981 Apr; 250(2):273-8. PubMed ID: 7271387
[TBL] [Abstract][Full Text] [Related]
15. The effect of dopamine administration on the activity of the renin-angiotensin-aldosterone system in sick preterm infants.
Sulyok E; Seri I; Tulassay T; Kiszel J; Ertl T
Eur J Pediatr; 1985 Jan; 143(3):191-3. PubMed ID: 3886384
[TBL] [Abstract][Full Text] [Related]
16. The effect of metoclopramide and haloperidol on plasma renin activity and aldosterone levels in rats.
Jungmann E; Wächtler M; Schwedes U; Usadel KH; Schöffling K
Res Exp Med (Berl); 1983; 183(2):133-8. PubMed ID: 6361937
[TBL] [Abstract][Full Text] [Related]
17. Evidence that endogenous somatostatin (SRIF) exerts a tonic inhibitory effect on the rat renin--angiotensin--aldosterone system.
Mazzocchi G; Malendowicz LK; Meneghelli V; Nussdorfer GG
In Vivo; 1992; 6(1):9-12. PubMed ID: 1352707
[TBL] [Abstract][Full Text] [Related]
18. Effects of central and peripheral dopamine antagonism on aldosterone secretion: evidence for adrenal mechanism.
Stern N; Eggena P; Chandler W; Tuck ML
Am J Physiol; 1989 Oct; 257(4 Pt 1):E588-94. PubMed ID: 2679132
[TBL] [Abstract][Full Text] [Related]
19. Aldosterone suppression with dopamine infusion in low-renin hypertension.
Holland OB; Thomas C; Brown H; Schindewolf D; Hillier Y; Gomez-Sanchez C
J Clin Invest; 1983 Sep; 72(3):754-66. PubMed ID: 6309909
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of aldosterone secretion by metoclopramide is not affected by chronic converting enzyme inhibition.
Dupont AG; Vanderniepen P; Smitz JJ; Six RO
Eur J Clin Pharmacol; 1985; 29(2):207-10. PubMed ID: 3000795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
